Luke J. McGeoch , Sarah Foulkes , Heather Whitaker , Katie Munro , Jameel Khawam , Dominic Sparkes , Andre Charlett , Colin S. Brown , Ana Atti , Jasmin Islam , Susan Hopkins , Nick Andrews , Victoria J. Hall
{"title":"2023-24年冬季英国卫生保健工作者流感疫苗预防感染的有效性:SIREN队列研究","authors":"Luke J. McGeoch , Sarah Foulkes , Heather Whitaker , Katie Munro , Jameel Khawam , Dominic Sparkes , Andre Charlett , Colin S. Brown , Ana Atti , Jasmin Islam , Susan Hopkins , Nick Andrews , Victoria J. Hall","doi":"10.1016/j.jinf.2025.106585","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To determine vaccine effectiveness against influenza infection among UK healthcare workers between 1 September 2023 and 31 March 2024.</div></div><div><h3>Methods</h3><div>We conducted a prospective cohort study, including hospital-based healthcare workers (HCWs) enrolled in the SARS-CoV-2 Immunity & Reinfection Evaluation (SIREN) study. Participants completed fortnightly influenza PCR testing and questionnaires. Influenza vaccination status was identified from national vaccination records and questionnaires. Vaccine effectiveness against PCR-positive influenza was estimated using Cox regression adjusted for age group, sex, chronic disease status, patient-facing role, and region. Case-control and test-negative case-control (TNCC) analyses, using multivariable logistic regression, were also performed.</div></div><div><h3>Results</h3><div>Among 4934 participants, median age was 55 years (IQR 47–60 years) and most were female (78.7%) and white (85.6%). Overall, 3857 (78.2%) received influenza vaccination and 266 (5.4%) tested positive for influenza, of which 227 (85.3%) reported acute respiratory infection symptoms. Adjusted vaccine effectiveness was 39.9% (95% confidence interval 21.8 – 53.8), and similar using case-control (41.2%, 22.5 – 55.2) and TNCC (45.9%, 21.8 – 62.2) approaches.</div></div><div><h3>Conclusions</h3><div>Influenza vaccine effectiveness was 40%, consistent with estimates for symptomatic patients. Applied to the combined UK healthcare workforce, this potentially translates to prevention of over 50,000 infections. These findings emphasise the importance of seasonal influenza vaccination to reduce healthcare workers infections and thereby protect patients and reduce workforce pressures.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"91 3","pages":"Article 106585"},"PeriodicalIF":11.9000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of influenza vaccination against infection in UK healthcare workers during winter 2023-24: The SIREN cohort study\",\"authors\":\"Luke J. McGeoch , Sarah Foulkes , Heather Whitaker , Katie Munro , Jameel Khawam , Dominic Sparkes , Andre Charlett , Colin S. Brown , Ana Atti , Jasmin Islam , Susan Hopkins , Nick Andrews , Victoria J. Hall\",\"doi\":\"10.1016/j.jinf.2025.106585\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To determine vaccine effectiveness against influenza infection among UK healthcare workers between 1 September 2023 and 31 March 2024.</div></div><div><h3>Methods</h3><div>We conducted a prospective cohort study, including hospital-based healthcare workers (HCWs) enrolled in the SARS-CoV-2 Immunity & Reinfection Evaluation (SIREN) study. Participants completed fortnightly influenza PCR testing and questionnaires. Influenza vaccination status was identified from national vaccination records and questionnaires. Vaccine effectiveness against PCR-positive influenza was estimated using Cox regression adjusted for age group, sex, chronic disease status, patient-facing role, and region. Case-control and test-negative case-control (TNCC) analyses, using multivariable logistic regression, were also performed.</div></div><div><h3>Results</h3><div>Among 4934 participants, median age was 55 years (IQR 47–60 years) and most were female (78.7%) and white (85.6%). Overall, 3857 (78.2%) received influenza vaccination and 266 (5.4%) tested positive for influenza, of which 227 (85.3%) reported acute respiratory infection symptoms. Adjusted vaccine effectiveness was 39.9% (95% confidence interval 21.8 – 53.8), and similar using case-control (41.2%, 22.5 – 55.2) and TNCC (45.9%, 21.8 – 62.2) approaches.</div></div><div><h3>Conclusions</h3><div>Influenza vaccine effectiveness was 40%, consistent with estimates for symptomatic patients. Applied to the combined UK healthcare workforce, this potentially translates to prevention of over 50,000 infections. These findings emphasise the importance of seasonal influenza vaccination to reduce healthcare workers infections and thereby protect patients and reduce workforce pressures.</div></div>\",\"PeriodicalId\":50180,\"journal\":{\"name\":\"Journal of Infection\",\"volume\":\"91 3\",\"pages\":\"Article 106585\"},\"PeriodicalIF\":11.9000,\"publicationDate\":\"2025-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163445325001859\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163445325001859","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Effectiveness of influenza vaccination against infection in UK healthcare workers during winter 2023-24: The SIREN cohort study
Objectives
To determine vaccine effectiveness against influenza infection among UK healthcare workers between 1 September 2023 and 31 March 2024.
Methods
We conducted a prospective cohort study, including hospital-based healthcare workers (HCWs) enrolled in the SARS-CoV-2 Immunity & Reinfection Evaluation (SIREN) study. Participants completed fortnightly influenza PCR testing and questionnaires. Influenza vaccination status was identified from national vaccination records and questionnaires. Vaccine effectiveness against PCR-positive influenza was estimated using Cox regression adjusted for age group, sex, chronic disease status, patient-facing role, and region. Case-control and test-negative case-control (TNCC) analyses, using multivariable logistic regression, were also performed.
Results
Among 4934 participants, median age was 55 years (IQR 47–60 years) and most were female (78.7%) and white (85.6%). Overall, 3857 (78.2%) received influenza vaccination and 266 (5.4%) tested positive for influenza, of which 227 (85.3%) reported acute respiratory infection symptoms. Adjusted vaccine effectiveness was 39.9% (95% confidence interval 21.8 – 53.8), and similar using case-control (41.2%, 22.5 – 55.2) and TNCC (45.9%, 21.8 – 62.2) approaches.
Conclusions
Influenza vaccine effectiveness was 40%, consistent with estimates for symptomatic patients. Applied to the combined UK healthcare workforce, this potentially translates to prevention of over 50,000 infections. These findings emphasise the importance of seasonal influenza vaccination to reduce healthcare workers infections and thereby protect patients and reduce workforce pressures.
期刊介绍:
The Journal of Infection publishes original papers on all aspects of infection - clinical, microbiological and epidemiological. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in the ever-changing field of infection.
Each issue brings you Editorials that describe current or controversial topics of interest, high quality Reviews to keep you in touch with the latest developments in specific fields of interest, an Epidemiology section reporting studies in the hospital and the general community, and a lively correspondence section.